Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days
- Yoshitaka Sato
- , Mitsutaka Iguchi
- , Yoshiaki Kato
- , Hiroshi Morioka
- , Aki Hirabayashi
- , Nobuyuki Tetsuka
- , Yuka Tomita
- , Daizo Kato
- , Kiyofumi Yamada
- , Hiroshi Kimura
- , Tetsuya Yagi
Research output: Contribution to journal › Article › peer-review
7
Link opens in a new tab
Citations
(Scopus)